| | |
ASPsiRNA information |
siRNA Id: | aspsirna3199
|
siRNA Name: | siRNA-s
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | CACAGGAAGGUCGUCAGCU
|
ASP-siRNA (As strand 3'->5'): | UACAGGAAGGUCGUCAGCU
|
Mismatch position in siRNA: | U19C |
Gene Information |
Gene Name | tumor protein p63 (TP63) |
Target Sequence (5'->3'): | CATCCCCTCCAACACCGACTACCCAGGCCCGCACAGTTTCGACG
|
Wild allele (5'->3'): | GUGUCCUUCCAGCAGUCGA
|
Mutant allele (5'->3'): | AUGUCCUUCCAGCAGUCGA
|
Position of siRNA on target gene: | 394-412
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_001114980.1 |
Cytogenic location: | 3q28 |
Chromosomal coordinates: | 3:189,566,860-189,897,278 |
UniProt ID: | Q9H3D4 |
HUGO ID: | 15979 |
Reference SNp(RefSNP): | rs19392114 |
Disease/Mutation information |
Target Mutation: | p.Arg132His,c.394G>A
|
Matation type/variant: | Single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_007550.1:g.237903G>A
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome 3 (EEC3) |
Clinical Resources |
ClinVar ID: | 161514 |
KEGG disease ID: | NA |
OMIM ID: | 604292 |
COSMIC: | TP63 |
DECIPHER: | TP63 |
GeneTests: | TP63 |
ASP siRNA details |
Mutant allele (5'->3'): | AUGUCCUUCCAGCAGUCGA
|
ASP-siRNA (As strand 3'->5'): | UACAGGAAGGUCGUCAGCU
|
Percentage efficacy of ASP-siRNA for mutant allele: | 40
|
Wild allele (5'->3'): | GUGUCCUUCCAGCAGUCGA
|
ASP-siRNA (As strand 3'->5'): | UACAGGAAGGUCGUCAGCU
|
Percentage efficacy of ASP-siRNA for wild allele: | 40
|
Relative difference: | 0
|
Wild siRNA details |
Wild allele (5'->3'): | GUGUCCUUCCAGCAGUCGA
|
Wild siRNA (As strand 3'->5'): | CACAGGAAGGUCGUCAGCU
|
Percentage efficacy of wild siRNA for wild allele: | 45
|
Wild allele (5'->3'): | GUGUCCUUCCAGCAGUCGA
|
ASP-siRNA (As strand 3'->5'): | UACAGGAAGGUCGUCAGCU
|
Percentage efficacy of Wild sirna for mutant allele: | 65
|
Relative difference : | -20
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HEK293T |
Experimental technique used: | Western blot |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Exiqon |
Post-transfection duration: | 72 hours |
Concentration used: | 100 microM |
Reference: | 26891374 |
Delivery method: | Transfection |
'Article title: | Correction of mutant p63 in EEC syndrome using siRNA mediated allele specific silencing restores defective stem cell function |
'Authors: | Barbaro V, Nasti AA, Del Vecchio C, Ferrari S, Migliorati A, Raffa P, Lariccia V, Nespeca P, Biasolo M, Willoughby CE4, Ponzin D, Palù G, Parolin C, Di Iorio E,. |
'Journal Reference: | Stem Cells. 2016 Feb 17. doi: 10.1002/stem.2343 |
'